Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

Bibliographic Details
Main Authors: Horne, Zachary D, Clump, David A, Vargo, John A, Shah, Samir, Beriwal, Sushil, Burton, Steven A, Quinn, Annette E, Schuchert, Matthew J, Landreneau, Rodney J, Christie, Neil A, Luketich, James D, Heron, Dwight E
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922961/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922961/

Similar Items